Financials
- Market Capitalization 24.34 M
- Employee 5
- Founded 1992
- CEO N/A
- Website www.markertherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000GMZP09
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4501 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.52 USD | -4.55% | -3.82% | +6.33% | +227.27% | 25.15 M USD | ||
| 4504 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.84 USD | +1.66% | -3.66% | -25.20% | -48.89% | 24.54 M USD | ||
| 4512 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.51 USD | -1.18% | -3.09% | -1.18% | -20.06% | 23.72 M USD | ||
| 4513 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 14.24 USD | -15.74% | +6.19% | +13.20% | +143.42% | 23.05 M USD |
Frequently asked questions about Marker Therapeutics, Inc. Common Stock
What is the Marker Therapeutics, Inc. Common Stock stock price today?
The current price of Marker Therapeutics, Inc. Common Stock (MRKR) is 1.46. Over the past 24 hours, the stock has changed by -4.61%. Follow the MRKR chart for real-time price dynamics.
What is the stock ticker of Marker Therapeutics, Inc. Common Stock?
Marker Therapeutics, Inc. Common Stock trades under the ticker MRKR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Marker Therapeutics, Inc. Common Stock stock going up?
MRKR has changed by +4.29% over the last week, +22.69% over the last month, and +48.98% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Marker Therapeutics, Inc. Common Stock?
Marker Therapeutics, Inc. Common Stock currently has a market capitalization of 24.34 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Marker Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Marker Therapeutics, Inc. Common Stock reported earnings of -0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Marker Therapeutics, Inc. Common Stock net income for the last quarter?
Marker Therapeutics, Inc. Common Stock reported net income of -1.83 M for the last quarter. The previous quarter showed -3.18 M, which means net income changed by +42.56%.
How many employees does Marker Therapeutics, Inc. Common Stock have?
As of the latest available data, Marker Therapeutics, Inc. Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Marker Therapeutics, Inc. Common Stock stock?
You can buy Marker Therapeutics, Inc. Common Stock (MRKR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Marker Therapeutics, Inc. Common Stock stock?
Investing in Marker Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MRKR chart and related analysis on metatrader.com as part of your research.